New imaging technique sheds light on oxygen levels in sarcoma tumors
NCT ID NCT03418818
First seen Mar 14, 2026 · Last updated May 12, 2026 · Updated 10 times
Summary
This study looks at whether a special PET scan combined with MRI can measure low oxygen levels (hypoxia) in soft tissue sarcoma tumors. About 70 adults with high-risk sarcoma will receive an injection of a radioactive tracer called FAZA before their standard treatment. The goal is to better understand tumor hypoxia, not to treat the disease. Participants are followed up by phone two days after the scan to check for any side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University Health Network
Toronto, Ontario, L4W4C2, Canada
Conditions
Explore the condition pages connected to this study.